Hillenbrand's Fading Fortune: Why It's Time to Bid Farewell
Tech Titan Under Pressure: Jefferies Slaps 'Sell' Rating on Apple, Predicting a Steep 20% Decline
Bloom Energy: Unmasking the AI Hype and the Reality of Its Fuel Cell Future
Apellis Pharmaceuticals Faces Investor Jitters as Goldman Sachs Issues "Sell" Rating on Escalating Competitive Threats
Reddit's IPO Hype: A Smoke Screen for Stagnating User Growth?
The AI Irony: Is Upstart Destined to Be Eaten by Its Own Creation?
The Siren's Warning: Why Motilal Oswal Sees Vodafone Idea Tumbling to Rs 6
Glenmark Pharma: Why Analysts Are Sounding the Alarm Bells